Chinese Journal of Integrative Medicine

, Volume 20, Issue 11, pp 850–856 | Cite as

Effects of curcumin on pain threshold and on the expression of nuclear factor κ B and CX3C receptor 1 after sciatic nerve chronic constrictive injury in rats

  • Hong Cao (曹 红)Email author
  • Jin-wei Zheng (郑晋伟)
  • Jia-jia Li (李佳佳)
  • Bo Meng (孟 波)
  • Jun Li (李 军)
  • Ren-shan Ge (葛仁山)
Original Article



To investigate the effects of curcumin on pain threshold and the expressions of nuclear factor κ B (NF-κ B) and CX3C chemokine receptor 1 (CX3CR1) in spinal cord and dorsal root ganglion (DRG) of the rats with sciatic nerve chronic constrictive injury.


One hundred and twenty male Sprague Dawley rats, weighing 220–250 g, were randomly divided into 4 groups. Sham surgery (sham) group: the sciatic nerves of rats were only made apart but not ligated; chronic constrictive injury (CCI) group: the sciatic nerves of rats were only ligated without any drug treatment; curcumin treated injury (Cur) model group: the rats were administrated with curcumin 100 mg/(kg·d) by intraperitoneal injection for 14 days after CCI; solvent control (SC) group: the rats were administrated with the solvent at the same dose for 14 days after CCI. Thermal withdrawal latency (TWL) and mechanical withdrawal threshold (MWT) of rats were respectively measured on pre-operative day 2 and postoperative day 1, 3, 5, 7, 10 and 14. The lumbar segment L4–5 of the spinal cord and the L4, L5 DRG was removed at post-operative day 3, 7 and 14. The change of nuclear factor κ B (NF-κ B) p65 expression was detected by Western blotting while the expression of CX3CR1 was determined by immunohistochemical staining.


Compared with the sham group, the TWL and MWT of rats in the CCI group were significantly decreased on each post-operative day (P<0.01), which reached a nadir on the 3rd day after CCI, and the expressions of NF-κ B p65 and CX3CR1 were markedly increased in spinal cord dorsal horn and DRG. In the Cur group, the TWL of rats were significantly increased than those in the CCI group on post-operative day 7, 10 and 14 (P<0.05) and MWT increased than those in the CCI group on post-operative day 10 and 14 (P<0.05). In addition, the administration of curcumin significantly decreased the positive expressions of NF-κ B p65 and CX3CR1 in spinal cord and DRG (P<0.05).


Our study suggests that curcumin could ameliorate the CCI-induced neuropathic pain, probably through inhibiting CX3CR1 expression by the activation of NF-κ B p65 in spinal cord and DRG.


curcumin neuropathic pain microglia nuclear factor κ B CX3C chemokine receptor 1 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Costigan M, Scholz J, Woolf CJ. NeuroPathic pain: a maladaptive response of the nervous system to damage. Annu Rev Neurosci 2009;32:1–32.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Ledeboer A, Gamanos M, Lai W, Martin D, Maier SF, Watkins LR, et al. Involvement of spinal cord nuclear factor B activation in rat models of proinflammatory cytokine-mediated pain facilitation. Eur J Neurosci 2005;22:1977–1986.PubMedCrossRefGoogle Scholar
  3. 3.
    Verge GM, Milligan ED, Maier SF, Watkins LR, Naeve GS, Foster AC. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur J Neurosci 2004;20:1150–1160.PubMedCrossRefGoogle Scholar
  4. 4.
    Pan YD, Guo QL, Wang E, Ye Z, He ZH, Zou WY, et al. Intrathecal infusion of pyrrolidine dithiocarbamate for the prevention and reversal of neuropathic pain in rats using a sciatic chronic constriction injury model. Reg Anesth Pain Med 2010;35:231–237.PubMedCrossRefGoogle Scholar
  5. 5.
    Ji RR, Strichartz G. Cell signaling and the genesis of neuropathic pain. Sci STKE 2004 (252), reE14.Google Scholar
  6. 6.
    Shen BL, Yu XD, Cao H. Effect of curcumin on diabetic neuropathic pain in rats. Chin J Anesthesiol (Chin) 2009;29:626–629.Google Scholar
  7. 7.
    Li X, Cao H, Lian QQ. The effect of p-ERK, p-CREB, c-fos in curcumin treat neuropathic pain of rats. Chin J Appl Physiol (Chin) 2009;25:418–422.Google Scholar
  8. 8.
    Narita M, Kaneko C, Miyoshi K, Nagumo Y, Kuzumaki N, Nakajima M, et al. Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdale. Neuropsychopharmacol 2006;31:739–750.CrossRefGoogle Scholar
  9. 9.
    Clark AK, Yip PK, Grist J, Gentry C, Staniland AA, Marchand F, et al. Inhibition of spinal microglialcathepsin S for the reversal of neuropathic pain. Proc Natl Acad Sci USA 2007;104:10655–10660.PubMedCentralPubMedCrossRefGoogle Scholar
  10. 10.
    Bennett GJ, Xie YK. A peripheral mononeuropathy in rat produces disorders of pain sensation like those seen in man. Pain 1988;33:87–107.PubMedCrossRefGoogle Scholar
  11. 11.
    Hu P, Bembrick AL, Keay KA, McLachlan EM. Immune cell involvement in dorsal root ganglia and spinal cord after chronic constriction or transection of the rat sciatic nerve. Brain Behav Immun 2007;21:599–616.PubMedCrossRefGoogle Scholar
  12. 12.
    Hanisch UK. Microglia as a source and target of cytokines. Glia 2002;40:140–155.PubMedCrossRefGoogle Scholar
  13. 13.
    Raghavendra V, Tanga F, DeLeo JA. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 2003;306:624–630.PubMedCrossRefGoogle Scholar
  14. 14.
    Milligan ED, Zapata V, Chacur M, Schoeniger D, Biedenkapp J, O’Connor KA, et al. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur J Neurosci 2004;20:2294–2302.PubMedCrossRefGoogle Scholar
  15. 15.
    Sun S, Cao H, Han M, Li TT, Pan HL, Zhao ZQ, et al. New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of mono-arthritis. Pain 2007;129:64–75.PubMedCrossRefGoogle Scholar
  16. 16.
    Tsuda M, Mizokoshi A, Shigemoto-Mogami Y, Koizumi S, Inoue K. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury. Glia 2004;45:89–95.PubMedCrossRefGoogle Scholar
  17. 17.
    Zhuang ZY, Kawasaki Y, Tan PH, Wen YR, Huang J, Ji RR. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun 2007;21:642–651.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Manning DC. New and emerging pharmacological targets for neuropathic pain. Curr Pain Headache Rep 2004;8:192–198.PubMedCrossRefGoogle Scholar
  19. 19.
    Sommer C, Kress M. Recent findings on how proinflammatory cytokine cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004;361:184–187.PubMedCrossRefGoogle Scholar
  20. 20.
    Sakaue G, Shimaoka M, Fukuoka T, Hiroi T, Inoue T, Hashimoto N, et al. NF-kappa B decoy suppresses cytokine expression and thermal hyperalgesia in a rat neuropathic pain model. Neuroreport 2001;24:2079–2084.CrossRefGoogle Scholar
  21. 21.
    Pollock G, Pennypacker KR, Mémet S, Israël A, Saporta S. Activation of NF-kappa B in the mouse spinal cord following sciatic nerve transection. Exp Brain Res 2005;165:470–477.PubMedCrossRefGoogle Scholar
  22. 22.
    Lee HL, Lee KM, Son SJ, Hwang SH, Cho HJ. Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model. Neuroreport 2004;15:2807–2811.PubMedGoogle Scholar
  23. 23.
    Tegeder I, Niederberger E, Schmidt R, Kunz S, Gühring H, Ritzeler O, et al. Specific inhibition of Ikappa B kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J Neurosci 2004;24:1637–1645.PubMedCrossRefGoogle Scholar
  24. 24.
    Ji RR. Suter MR. p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 2007;3:33–42.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Aggarwal S, Ichikawa H, Takada Y, Sandur SK, Shishodia S, Aggarwal BB. Curcumin down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of I κ B α kinase and Akt activation. Mol Pharmacol 2006;69:195–206.PubMedGoogle Scholar
  26. 26.
    Oh SW, Cha JY, Kim DY. Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-kappaB inhibition. J Ethnopharmacol 2010; Jul 17.Google Scholar
  27. 27.
    Pan YD, Guo QL, Wang E, Ye Z, He ZH, Zou WY, et al. Intrathecal infusion of pyrrolidine dithiocarbamate for the prevention and reversal of neuropathic pain in rats using a sciatic chronic constriction injury model. Reg Anesth Pain Med 2010;35:231–237.PubMedCrossRefGoogle Scholar

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Hong Cao (曹 红)
    • 1
    Email author
  • Jin-wei Zheng (郑晋伟)
    • 1
  • Jia-jia Li (李佳佳)
    • 1
  • Bo Meng (孟 波)
    • 1
  • Jun Li (李 军)
    • 1
  • Ren-shan Ge (葛仁山)
    • 1
  1. 1.Department of AnesthesiologyThe Second Affiliated Hospital of Wenzhou Medical CollegeWenzhou, Zhejiang ProvinceChina

Personalised recommendations